A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
Status:
Completed
Trial end date:
2021-06-22
Target enrollment:
Participant gender:
Summary
This study will evaluate the safe and effective dose conversion from synthetic T4 therapy to
Armour Thyroid therapy in participants who are euthyroid on a stable dose of synthetic T4.